« Back

JK Capital participated in the article of Neofeed on consolidation in the hemotherapy sector

Neofeed published today the case of H.Hemo, which, with the assistance of JK Capital, acquired more than 18 companies in the last two years, becoming one of the largest hemotherapy groups in Brazil.

25/08/2020

{"pt-br":"

O NeoFeedBrasil contou hoje o case da H.Hemo, que com a assessoria da JK Capital, adquiriu mais de 18 empresas nos último dois anos, tornando-se um dos maiores grupos de hemoterapia do país. O sócio da JK Capital, Luis Mazzarella Martins, participou da matéria e disse que há espaço para o grupo adquirir ainda mais companhias.


Leia a matéria completa: https://neofeed.com.br/blog/home/o-david-que-virou-um-golias-dos-bancos-de-sangue/

","en":"

Neofeed published today the case of H.Hemo, which, with the assistance of JK Capital, acquired more than 18 companies in the last two years, becoming one of the largest hemotherapy groups in Brazil. JK Capital partner Luís Mazzarella Martins participated in the story and said that there is potential for the group to acquire even more companies.


Read the full story: https://neofeed.com.br/blog/home/o-david-que-virou-um-golias-dos-bancos-de-sangue/

","es":""}
JK Capital collects data to ensure that this website works properly and to analyze its performance. We may also collect your data to manage your relationship with us and to better serve you. To learn more about our privacy and data protection practices, please access our Privacy Policy privacy policy